Skip to main content
. 2022 Oct 28;193:110135. doi: 10.1016/j.diabres.2022.110135

Table 2.

Clinical and patient reported outcomes at study entry versus end of study.

study entry end of study p
Metabolic measures M (SD) (n = 99)
HbA1c (%) 7.8 (1.0) 7.8 (0.8) 0.719b
HbA1c (mmol/mol) 62 (10) 62 (9)
Time in Range (%) 56.4 (14.7) 58.0 (12.7) 0.090b
Time below Range (%) 2.06 (1.70) 2.37 (1.99) 0.203b
Mean sensor glucose mg/dl 179.8 (27.7) 174.5 (22.9) 0.002b
Glucose management indicator GMI (%) 7.61 (0.66) 7.49 (0.55) 0.003b
BMI SDS 0.55 (0.91) 0.58 (0.87) 0.801b
Parental reported outcome measures (n = 87)
DTSQs parents: diabetes treatment satisfaction – total score (min-max 0-84) 57.08 (9.61) 60.36 (9.79) <0.001a
Parents’ overall treatment satisfaction (10 Items) (min-max 0-60) 43.57 (7.35) 45.64 (7.06) 0.001a
Parents’ satisfaction with perceived hypoglycemia (min-max 0-6) 3.66 (0.99) 3.93 (1.02) 0.035b
Parents’ satisfaction with perceived glycemic control (min-max 0-12) 6.46 (2.13) 6.97 (2.14) 0.021a
Parents’ satisfaction with perceived effect of treatment on their life (min-max 0-6) 3.51 (1.39) 3.82 (1.44) 0.026b
P-PAID diabetes burden and distress
P-PAID-C summed total score (min- max 16-96) parents of children 47.48 (12.81) 44.28 (14.23) 0.042a
P-PAID-T summed total score (min- max 15-90) parents of teens 50.63 (15.25) 45.08 (13.53) 0.003a

Table note: aAccording to paired samples t-Test pre-post or bWilcoxon test pre-post.